1996
DOI: 10.1001/archotol.1996.01890140057011
|View full text |Cite
|
Sign up to set email alerts
|

Transforming Growth Factor  1 Improves Wound Healing and Random Flap Survival in Normal and Irradiated Rats

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
43
0
1

Year Published

1998
1998
2018
2018

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 91 publications
(45 citation statements)
references
References 22 publications
1
43
0
1
Order By: Relevance
“…In another study, NALL et al 12 found that tensile strength tended to decrease in irradiated groups as compared to nonirradiated groups after a single 15-Gy dose, but the difference was not significant. Our results for the conventional group matched those of NALL et al 12 and clinical studies 9 ; the tissue strength decreased, but the difference was not significant. This was due to the tissuesparing effects of therapeutic RT in small daily fractions, rather than largefraction doses.…”
Section: Discussionmentioning
confidence: 92%
“…In another study, NALL et al 12 found that tensile strength tended to decrease in irradiated groups as compared to nonirradiated groups after a single 15-Gy dose, but the difference was not significant. Our results for the conventional group matched those of NALL et al 12 and clinical studies 9 ; the tissue strength decreased, but the difference was not significant. This was due to the tissuesparing effects of therapeutic RT in small daily fractions, rather than largefraction doses.…”
Section: Discussionmentioning
confidence: 92%
“…Pre-chinical models have demonstrated the effect of cytokines on healing of both irradiated and nonirradiated wounds [31][32][33][34][35][36][37][38][39]. An explanation for the lack of response seen in Protocol 2 may be that the placement of the fibroblast/fibrin implant into the deep wound of the muscle excision does not position the fibroblasts where they can participate in the healing of the skin.…”
Section: Discussionmentioning
confidence: 99%
“…Inhibition of bone resorption utilizing bisphosphonates has been shown to reduce bone mineral loss at anterior cruciate ligament entheses after joint injury (65). However, TGF-β, as a crucial growth factor, may be activated by means other than osteoclast bone resorption and plays an important role in a number of processes: inflammation, cell migration, stimulating angiogenesis, epithelial mesenchymal transition (EMT), endothelial mesenchymal transition (EndoMT), and remodeling of the new ECM (66)(67)(68)(69). Therefore, drugs targeting osteoclast resorption may not be as effective as directly targeting TGF-β signaling and would need further preclinical studies to validate.…”
Section: Methodsmentioning
confidence: 99%